SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 57.07 Million USD | -3.51% |
| 2022 | 58.99 Million USD | 18.99% |
| 2021 | 49.58 Million USD | 23.45% |
| 2020 | 40.16 Million USD | -4.11% |
| 2019 | 41.88 Million USD | -14.28% |
| 2018 | 48.86 Million USD | 30.73% |
| 2017 | 37.37 Million USD | -7.82% |
| 2016 | 40.54 Million USD | 17.26% |
| 2015 | 34.58 Million USD | -13.5% |
| 2014 | 39.97 Million USD | 34.72% |
| 2013 | 29.67 Million USD | 10.16% |
| 2012 | 26.93 Million USD | -36.43% |
| 2011 | 42.37 Million USD | -15.68% |
| 2010 | 50.25 Million USD | 4.93% |
| 2009 | 47.89 Million USD | 7.49% |
| 2008 | 44.55 Million USD | -28.28% |
| 2007 | 62.12 Million USD | -1.15% |
| 2006 | 62.84 Million USD | -36.55% |
| 2005 | 99.04 Million USD | -3.89% |
| 2004 | 103.05 Million USD | 4.32% |
| 2003 | 98.78 Million USD | 10.0% |
| 2002 | 89.8 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 13.93 Million USD | -0.72% |
| 2024 Q2 | 13.93 Million USD | 0.0% |
| 2023 Q1 | 14.5 Million USD | -48.1% |
| 2023 Q3 | 14.03 Million USD | -51.12% |
| 2023 Q2 | 28.71 Million USD | 97.98% |
| 2023 Q4 | 14.03 Million USD | 0.0% |
| 2023 FY | 56.92 Million USD | -3.51% |
| 2022 Q2 | 30.77 Million USD | 99.18% |
| 2022 Q3 | 14.04 Million USD | -54.35% |
| 2022 FY | 58.99 Million USD | 18.99% |
| 2022 Q4 | 27.94 Million USD | 98.91% |
| 2022 Q1 | 15.45 Million USD | 8.23% |
| 2021 FY | 49.58 Million USD | 23.45% |
| 2021 Q2 | 10.51 Million USD | 0.0% |
| 2021 Q1 | 10.51 Million USD | -49.54% |
| 2021 Q3 | 14.27 Million USD | 35.75% |
| 2021 Q4 | 14.27 Million USD | 0.0% |
| 2020 Q2 | 19.6 Million USD | 101.11% |
| 2020 Q3 | 10.33 Million USD | -47.27% |
| 2020 FY | 40.16 Million USD | -4.11% |
| 2020 Q4 | 20.83 Million USD | 101.63% |
| 2020 Q1 | 9.74 Million USD | -51.68% |
| 2019 Q2 | 21.84 Million USD | 100.28% |
| 2019 Q1 | 10.9 Million USD | -44.84% |
| 2019 Q3 | 10.03 Million USD | -54.06% |
| 2019 FY | 41.88 Million USD | -14.28% |
| 2019 Q4 | 20.17 Million USD | 101.01% |
| 2018 Q4 | 19.77 Million USD | 99.27% |
| 2018 Q2 | 28.9 Million USD | 99.21% |
| 2018 Q1 | 14.5 Million USD | 49.13% |
| 2018 FY | 48.86 Million USD | 30.73% |
| 2018 Q3 | 9.92 Million USD | -65.67% |
| 2017 Q1 | 8.96 Million USD | -1.88% |
| 2017 FY | 37.37 Million USD | -7.82% |
| 2017 Q4 | 9.72 Million USD | 0.0% |
| 2017 Q3 | 9.72 Million USD | 8.57% |
| 2017 Q2 | 8.96 Million USD | 0.0% |
| 2016 Q3 | 9.13 Million USD | 5.32% |
| 2016 Q1 | 8.67 Million USD | -5.18% |
| 2016 Q2 | 8.67 Million USD | 0.0% |
| 2016 FY | 40.54 Million USD | 17.26% |
| 2016 Q4 | 9.13 Million USD | 0.0% |
| 2015 FY | 34.58 Million USD | -13.5% |
| 2015 Q4 | 9.14 Million USD | 0.0% |
| 2015 Q3 | 9.14 Million USD | -20.95% |
| 2015 Q2 | 11.56 Million USD | 21.57% |
| 2015 Q1 | 9.51 Million USD | 5.17% |
| 2014 FY | 39.97 Million USD | 34.72% |
| 2014 Q1 | 10.64 Million USD | 37.63% |
| 2014 Q2 | 10.27 Million USD | -3.47% |
| 2014 Q3 | 10.01 Million USD | -2.56% |
| 2014 Q4 | 9.04 Million USD | -9.62% |
| 2013 FY | 29.67 Million USD | 10.16% |
| 2013 Q4 | 7.73 Million USD | 4.6% |
| 2013 Q3 | 7.39 Million USD | -0.2% |
| 2013 Q2 | 7.4 Million USD | 3.75% |
| 2013 Q1 | 7.14 Million USD | 3.27% |
| 2012 Q3 | 6.46 Million USD | -2.71% |
| 2012 FY | 26.93 Million USD | -36.43% |
| 2012 Q4 | 6.91 Million USD | 6.95% |
| 2012 Q1 | 6.91 Million USD | -23.74% |
| 2012 Q2 | 6.64 Million USD | -3.89% |
| 2011 FY | 42.37 Million USD | -15.68% |
| 2011 Q4 | 9.06 Million USD | -11.24% |
| 2011 Q3 | 10.21 Million USD | -11.96% |
| 2011 Q1 | 11.49 Million USD | -15.02% |
| 2011 Q2 | 11.6 Million USD | 0.96% |
| 2010 Q1 | 12.37 Million USD | -5.88% |
| 2010 Q4 | 13.52 Million USD | 9.34% |
| 2010 Q3 | 12.36 Million USD | 3.17% |
| 2010 FY | 50.25 Million USD | 4.93% |
| 2010 Q2 | 11.98 Million USD | -3.12% |
| 2009 Q4 | 13.14 Million USD | 3.45% |
| 2009 FY | 47.89 Million USD | 7.49% |
| 2009 Q3 | 12.7 Million USD | 12.09% |
| 2009 Q2 | 11.33 Million USD | 5.97% |
| 2009 Q1 | 10.69 Million USD | 0.0% |
| 2008 Q2 | 11.04 Million USD | 0.0% |
| 2008 FY | 44.55 Million USD | -28.28% |
| 2007 FY | 62.12 Million USD | -1.15% |
| 2006 FY | 62.84 Million USD | -36.55% |
| 2005 FY | 99.04 Million USD | -3.89% |
| 2004 FY | 103.05 Million USD | 4.32% |
| 2003 FY | 98.78 Million USD | 10.0% |
| 2002 FY | 89.8 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Augmedix, Inc. | 44.85 Million USD | -27.243% |
| OneMedNet Corporation | 1.02 Million USD | -5486.546% |
| Minerva Surgical, Inc. | 50.29 Million USD | -13.483% |
| CareCloud, Inc. | 117.05 Million USD | 51.243% |
| CareCloud, Inc. | 117.05 Million USD | 51.243% |
| HealthEquity, Inc. | 999.58 Million USD | 94.29% |
| iCoreConnect Inc. | 8.15 Million USD | -600.17% |
| Progyny, Inc. | 1.08 Billion USD | 94.757% |
| Renalytix Plc | 2.28 Million USD | -2393.447% |
| Schrödinger, Inc. | 216.66 Million USD | 73.658% |
| Simulations Plus, Inc. | 70.01 Million USD | 18.479% |
| SOPHiA GENETICS SA | 62.37 Million USD | 8.491% |
| Omnicell, Inc. | 1.14 Billion USD | 95.024% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.353% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -152.589% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 91.45% |
| Ontrak, Inc. | 12.74 Million USD | -347.893% |
| Nutex Health, Inc. | 247.64 Million USD | 76.953% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.708% |
| Sharecare, Inc. | 445.25 Million USD | 87.181% |
| Aclarion, Inc. | 75.4 Thousand USD | -75592.271% |
| CareMax, Inc. | 751.1 Million USD | 92.401% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -87707.692% |
| Forian Inc. | 20.48 Million USD | -178.668% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -87707.692% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 71.824% |
| SCWorx Corp. | 3.8 Million USD | -1400.022% |
| Definitive Healthcare Corp. | 251.41 Million USD | 77.298% |
| 10x Genomics, Inc. | 618.72 Million USD | 90.775% |
| Zhongchao Inc. | 19.43 Million USD | -193.687% |
| Accolade, Inc. | 414.29 Million USD | 86.223% |
| MSP Recovery, Inc. | 7.7 Million USD | -640.753% |
| R1 RCM Inc. | 2.25 Billion USD | 97.468% |
| Spok Holdings, Inc. | 139.02 Million USD | 58.946% |
| Privia Health Group, Inc. | 1.65 Billion USD | 96.557% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1439.88% |
| TruBridge, Inc. | 339.43 Million USD | 83.185% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.353% |
| Sharecare, Inc. | 445.25 Million USD | 87.181% |
| Health Catalyst, Inc. | 295.93 Million USD | 80.714% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 92.393% |
| Premier, Inc. | 1.34 Billion USD | 95.761% |
| HealthStream, Inc. | 279.06 Million USD | 79.548% |
| Certara, Inc. | 354.33 Million USD | 83.892% |
| GeneDx Holdings Corp. | 202.56 Million USD | 71.824% |
| Ontrak, Inc. | 12.74 Million USD | -347.893% |
| CareCloud, Inc. | 117.05 Million USD | 51.243% |
| EUDA Health Holdings Limited | 3.7 Million USD | -1439.88% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -7702.535% |
| CareMax, Inc. | 751.1 Million USD | 92.401% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -71.897% |
| National Research Corporation | 148.58 Million USD | 61.586% |
| Aclarion, Inc. | 75.4 Thousand USD | -75592.271% |
| OptimizeRx Corporation | 71.52 Million USD | 20.199% |